Abstract: Medical safety needle assembly comprising a medical needle (14) having a distal and a proximal end and a stem extending there between, the needle having a tip at its distal end, the proximal end of the needle being connected to a tubing (15) with a connection hub for connecting the tubing (15) to a syringe (30), the connection being able to resist tensile loads, and a base plate (10) the needle (14) extending slidably through the base plate (10) and having an inserted position with the needle tip extending in distal direction from the base plate (10) and a retracted position with the needle tip being in a position inside a cavity of the base plate, characterized in that the needle comprises a first attachment element at its proximal side of the base plate (10), and the connection hub comprises a second attachment element (31) being able to engage with the first attachment element in order to pull the needle (14) through the base (10) plate into its retracted position.

Abstract: Medical safety needle assembly comprising a medical needle having a distal and a proximal end and a stem extending there between, the needle having a tip at its distal end, the proximal end of the needle being connectable to a fluid path, and the needle stem having a 80°-90° bend, and a safety device comprising a base plate and a housing the base plate and the housing enclosing together a cavity, the safety device being slidably arranged on the needle stem distal from the bend, and the needle stem passing through a distal opening in the base plate and a proximal opening in the housing, the needle having an inserted position with the needle tip extending in distal direction from the base plate and a retracted position with the needle tip being in a position inside the cavity, characterized in that the housing consists of a first part attached to the base plate and a second part (32) attached by means of extendible attachment elements (33) to the first part, wherein the proximal opening is arranged in the secon

Abstract: Synthetic peptides which have been shown to be FGF18 agonists are described. Topical compositions for decreasing, eliminating, or suppressing hair growth are disclosed herein. Methods for reducing hair growth, improving the appearance of skin, kits, and related cosmetic formulations are also provided herein.

Abstract: A check-in system for an dispensing items includes a computing device having an application installed thereon. The computing device is configured to check in a customer to notify the kiosk of a time range during which an order of the customer is picked up. The kiosk is configured to receive a check-in message from the computing device, receive the location of the computing device, receive a message indicative of the arrival of the customer at the automated tower, retrieve information of the order from an order database stored on a remote server, assemble the order based on the check-in message and the information of the order, and move the assembled order close to a pick-up location of the automated tower to facilitate pick-up of the assembled order.

Abstract: The compositions of various embodiments include a tocopherol phosphate mixture (TPM) comprising a liposome having a lipid bilayer and an internal aqueous compartment, a lipophilic ingredient, a polar solvent system, an alcohol, a base, and a water soluble phase, wherein the liposome is made of a tocopherol phosphate derivative, wherein the lipophilic ingredients are entrapped in the lipophilic bilayer of the liposome, and wherein a water soluble ingredient is dissolved in the water soluble phase and is in the internal compartment of the liposome. The methods include improving the look of skin particularly of the neck and décolletage, increasing expression of an extracellular matrix proteins in skin, improving a keloid scar in a subject, and improving aging skin. Additionally, methods for preparing the compositions are described herein.

Abstract: Aspects of the disclosure include a power system comprising at least one three-wire active harmonic filter (AHF) configured to be coupled to, and provide compensation current to, a three-phase load, at least one four-wire AHF configured to be coupled to, and provide compensation current to, the three-phase load, and a controller configured to determine a total compensation current to provide to the three-phase load, the total compensation current including a zero component and a non-zero component, determine an output capacity of the at least one three-wire AHF and the at least one four-wire AHF, calculate a current-compensation ratio based on the output capacity of the at least one three-wire AHF and the at least one four-wire AHF, and control the at least one four-wire AHF to provide at least a portion of the non-zero component of the total compensation current to the three-phase load based on the current-compensation ratio.

Abstract: A check-in system for an dispensing items includes a computing device having an application installed thereon. The computing device is configured to check in a customer to notify the kiosk of a time range during which an order of the customer is picked up. The kiosk is configured to receive a check-in message from the computing device, receive the location of the computing device, receive a message indicative of the arrival of the customer at the automated tower, retrieve information of the order from an order database stored on a remote server, assemble the order based on the check-in message and the information of the order, and move the assembled order close to a pick-up location of the automated tower to facilitate pick-up of the assembled order.

Abstract: The present disclosure provides thirteen synthetic peptides which have been shown to be FGF18 agonists. These synthetic peptides and topical compositions for decreasing, eliminating, or suppressing hair growth are disclosed herein. Methods for reducing hair growth, improving the appearance of skin, kits, and related cosmetic formulations are also provided herein.

Abstract: Compositions and topical formulations comprising a PPAR agonist complex comprising glyceryl linoleate, glyceryl linolenate, xymenynic acid, and Pterocarpus marsupium bark extract are described herein. Methods of inducing skin barrier repair, increasing the biosynthesis of barrier lipids and proteins in the skin, stimulating hair growth, treating acne and combinations thereof utilizing the composition and topical formulations are also provided herein.

Abstract: Aspects of the disclosure include a power system comprising at least one three-wire active harmonic filter (AHF) configured to be coupled to, and provide compensation current to, a three-phase load, at least one four-wire AHF configured to be coupled to, and provide compensation current to, the three-phase load, and a controller configured to determine a total compensation current to provide to the three-phase load, the total compensation current including a zero component and a non-zero component, determine an output capacity of the at least one three-wire AHF and the at least one four-wire AHF, calculate a current-compensation ratio based on the output capacity of the at least one three-wire AHF and the at least one four-wire AHF, and control the at least one four-wire AHF to provide at least a portion of the non-zero component of the total compensation current to the three-phase load based on the current-compensation ratio.

Abstract: The compositions of various embodiments include a tocopherol phosphate mixture (TPM) comprising a liposome having a lipid bilayer and an internal aqueous compartment, a lipophilic ingredient, a polar solvent system, an alcohol, a base, and a water soluble phase, wherein the liposome is made of a tocopherol phosphate derivative, wherein the lipophilic ingredients are entrapped in the lipophilic bilayer of the liposome, and wherein a water soluble ingredient is dissolved in the water soluble phase and is in the internal compartment of the liposome. The methods include improving the look of skin particularly of the neck and décolletage, increasing expression of an extracellular matrix proteins in skin, improving a keloid scar in a subject, and improving aging skin. Additionally, methods for preparing said compositions are described herein.

Abstract: Disclosed herein are methods, an apparatus, and a computer-readable medium product for sharing broadcast resources and validating usage of the broadcast resources according to an agreement between a plurality of broadcast virtual network operators (BVNOs). A method includes determining the plurality of spectrum resources corresponding to a length of a broadcast frame, and creating a plurality of physical layer pipes (PLPs) based on a plurality of internet protocol (IP) flows from the plurality of BVNOs. The method includes constructing the broadcast frame including the plurality of PLPs and generating a broadcast frame record based on transmission of the broadcast frame. The broadcast frame record can identify the plurality of spectrum resources shared between the plurality of BVNOs. The method includes updating the broadcast frame record with identification information of the plurality of BVNOs and the plurality of IP flows corresponding to the plurality of PLPs of the broadcast frame.